Debora Jorn - Jan 4, 2022 Form 4 Insider Report for VIVEVE MEDICAL, INC. (VIVE)

Role
Director
Signature
/s/ Jim Robbins, as Attorney-in-Fact
Stock symbol
VIVE
Transactions as of
Jan 4, 2022
Transactions value $
$0
Form type
4
Date filed
1/6/2022, 03:04 PM
Previous filing
Jun 25, 2021
Next filing
Jan 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIVE Non-Qualified Stock Option (Right to Purchase) Award $0 +22K $0.00 22K Jan 4, 2022 Common Stock 22K $1.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan, as amended (the "2013 Plan") and received 22,000 non-qualified stock options on January 4, 2022 (the "Grant Date"). The non-qualified stock options shall vest and become exercisable in 48 equal monthly installments from the Grant Date.